While the company reports its initiatives are starting to pay off, its Q3 filings show several areas of financial strain.

Charles River Laboratories presents with optimistic growth expectations that seem a stretch given the business's current performance. See why CRL stock is a Hold.

Farther Finance Advisors LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Dozens of researchers across Canada have joined a growing chorus of voices urging the federal government to halt the ...

Dozens of researchers across Canada, including renowned environmentalist David Suzuki, have joined a growing chorus of voices ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

By Sam Boughedda Charles River Laboratories (NYSE:CRL) shares plummeted over 14% Wednesday after the company said in its latest earnings report that it has received a subpoena from ...

NEW YORK, NY / ACCESSWIRE / November 18, 2024 / EW Healthcare Partners, a trans-Atlantic healthcare private equity firm, today announced that it has appointed Dr. Petri Vainio as Executive Chairman, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...